Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.11 billion. The enterprise value is $833.38 million.
| Market Cap | 1.11B |
| Enterprise Value | 833.38M |
Important Dates
The next estimated earnings date is Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 137.34 million shares outstanding. The number of shares has increased by 2.07% in one year.
| Current Share Class | 137.34M |
| Shares Outstanding | 137.34M |
| Shares Change (YoY) | +2.07% |
| Shares Change (QoQ) | +1.39% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 48.66% |
| Float | 133.43M |
Valuation Ratios
The trailing PE ratio is 202.50 and the forward PE ratio is 17.42.
| PE Ratio | 202.50 |
| Forward PE | 17.42 |
| PS Ratio | 4.93 |
| Forward PS | 4.17 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | 25.22 |
| P/OCF Ratio | 25.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.07, with an EV/FCF ratio of 18.89.
| EV / Earnings | 144.88 |
| EV / Sales | 3.54 |
| EV / EBITDA | 26.07 |
| EV / EBIT | 66.57 |
| EV / FCF | 18.89 |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.21.
| Current Ratio | 4.57 |
| Quick Ratio | 4.05 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | 2.42 |
| Debt / FCF | 1.80 |
| Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 1.52% and return on invested capital (ROIC) is 1.68%.
| Return on Equity (ROE) | 1.52% |
| Return on Assets (ROA) | 1.42% |
| Return on Invested Capital (ROIC) | 1.68% |
| Return on Capital Employed (ROCE) | 2.76% |
| Revenue Per Employee | $1.81M |
| Profits Per Employee | $44,246 |
| Employee Count | 130 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.24 |
Taxes
In the past 12 months, AUPH has paid $1.70 million in taxes.
| Income Tax | 1.70M |
| Effective Tax Rate | 22.77% |
Stock Price Statistics
The stock price has increased by +59.14% in the last 52 weeks. The beta is 1.21, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +59.14% |
| 50-Day Moving Average | 8.02 |
| 200-Day Moving Average | 7.55 |
| Relative Strength Index (RSI) | 54.62 |
| Average Volume (20 Days) | 1,294,057 |
Short Selling Information
The latest short interest is 11.49 million, so 8.37% of the outstanding shares have been sold short.
| Short Interest | 11.49M |
| Short Previous Month | 11.44M |
| Short % of Shares Out | 8.37% |
| Short % of Float | 8.61% |
| Short Ratio (days to cover) | 7.18 |
Income Statement
In the last 12 months, AUPH had revenue of $235.13 million and earned $5.75 million in profits. Earnings per share was $0.04.
| Revenue | 235.13M |
| Gross Profit | 186.10M |
| Operating Income | 12.52M |
| Pretax Income | -48.10M |
| Net Income | 5.75M |
| EBITDA | 31.96M |
| EBIT | 12.52M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $358.44 million in cash and $79.37 million in debt, giving a net cash position of $279.07 million or $2.03 per share.
| Cash & Cash Equivalents | 358.44M |
| Total Debt | 79.37M |
| Net Cash | 279.07M |
| Net Cash Per Share | $2.03 |
| Equity (Book Value) | 377.48M |
| Book Value Per Share | 2.68 |
| Working Capital | 348.83M |
Cash Flow
In the last 12 months, operating cash flow was $44.39 million and capital expenditures -$281,000, giving a free cash flow of $44.11 million.
| Operating Cash Flow | 44.39M |
| Capital Expenditures | -281,000 |
| Free Cash Flow | 44.11M |
| FCF Per Share | $0.32 |
Margins
Gross margin is 79.15%, with operating and profit margins of 5.32% and 2.45%.
| Gross Margin | 79.15% |
| Operating Margin | 5.32% |
| Pretax Margin | 3.17% |
| Profit Margin | 2.45% |
| EBITDA Margin | 13.59% |
| EBIT Margin | 5.32% |
| FCF Margin | 18.76% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.07% |
| Shareholder Yield | -2.07% |
| Earnings Yield | 0.52% |
| FCF Yield | 3.96% |
Analyst Forecast
The average price target for AUPH is $11.50, which is 41.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 41.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 11.56% |
| EPS Growth Forecast (5Y) | 95.27% |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02:1.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.02:1 |
Scores
AUPH has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.16 |
| Piotroski F-Score | 6 |